455 related articles for article (PubMed ID: 10878819)
1. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
Goldberg MS; Lansbury PT
Nat Cell Biol; 2000 Jul; 2(7):E115-9. PubMed ID: 10878819
[TBL] [Abstract][Full Text] [Related]
2. Genetics of Parkinson's disease.
Polymeropoulos MH
Ann N Y Acad Sci; 2000; 920():28-32. PubMed ID: 11193165
[TBL] [Abstract][Full Text] [Related]
3. [Molecular pathogenesis of familial Parkinson's disease].
Kitada T; Mizuno Y
Nihon Rinsho; 2000 Oct; 58(10):2016-21. PubMed ID: 11068440
[TBL] [Abstract][Full Text] [Related]
4. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
[TBL] [Abstract][Full Text] [Related]
5. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
6. Complex interactions in Parkinson's disease: a two-phased approach.
Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA
Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265
[TBL] [Abstract][Full Text] [Related]
7. Etiology of Parkinson's disease: Genetics and environment revisited.
Steece-Collier K; Maries E; Kordower JH
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13972-4. PubMed ID: 12391311
[No Abstract] [Full Text] [Related]
8. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
[TBL] [Abstract][Full Text] [Related]
9. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.
Lim KL; Dawson VL; Dawson TM
Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976
[TBL] [Abstract][Full Text] [Related]
10. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
Lansbury PT; Brice A
Curr Opin Cell Biol; 2002 Oct; 14(5):653-60. PubMed ID: 12231362
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
12. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
Lansbury PT; Brice A
Curr Opin Genet Dev; 2002 Jun; 12(3):299-306. PubMed ID: 12076673
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
McNaught KS; Olanow CW
Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein and Parkinson's disease.
Golbe LI
Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
[No Abstract] [Full Text] [Related]
15. Monogenic Parkinsonisms and the genetics of Parkinson's disease.
Bonifati V
Funct Neurol; 2001; 16(1):35-44. PubMed ID: 11396270
[No Abstract] [Full Text] [Related]
16. Recent advances in the genetics and pathogenesis of Parkinson disease.
Mouradian MM
Neurology; 2002 Jan; 58(2):179-85. PubMed ID: 11805242
[TBL] [Abstract][Full Text] [Related]
17. The genetics of Parkinson's disease.
de Silva HR; Khan NL; Wood NW
Curr Opin Genet Dev; 2000 Jun; 10(3):292-8. PubMed ID: 10826990
[TBL] [Abstract][Full Text] [Related]
18. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
Liu Y; Fallon L; Lashuel HA; Liu Z; Lansbury PT
Cell; 2002 Oct; 111(2):209-18. PubMed ID: 12408865
[TBL] [Abstract][Full Text] [Related]
19. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
Haywood AF; Staveley BE
BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
[TBL] [Abstract][Full Text] [Related]
20. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.
Volles MJ; Lansbury PT
Biochemistry; 2003 Jul; 42(26):7871-8. PubMed ID: 12834338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
